Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2017 3
2018 2
2019 2
2020 4
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial.
Corripio I, Roldán A, Sarró S, McKenna PJ, Alonso-Solís A, Rabella M, Díaz A, Puigdemont D, Pérez-Solà V, Álvarez E, Arévalo A, Padilla PP, Ruiz-Idiago JM, Rodríguez R, Molet J, Pomarol-Clotet E, Portella MJ. Corripio I, et al. Among authors: alonso solis a. EBioMedicine. 2020 Jan;51:102568. doi: 10.1016/j.ebiom.2019.11.029. Epub 2020 Jan 8. EBioMedicine. 2020. PMID: 31927311 Free PMC article. Clinical Trial.
Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets.
Aibar-Durán JÁ, Corripio Collado I, Roldán Bejarano A, Sánchez Nevado R, Aracil Bolanos I, García-Cornet J, Alonso-Solís A, Grasa Bello EM, de Quintana Schmidt C, Muñoz Hernández F, Molet Teixidó J, Rodríguez RR. Aibar-Durán JÁ, et al. Among authors: alonso solis a. J Psychiatr Res. 2023 Jul;163:296-304. doi: 10.1016/j.jpsychires.2023.05.056. Epub 2023 May 18. J Psychiatr Res. 2023. PMID: 37245316
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study.
Grasa E, Seppälä J, Alonso-Solis A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J; m-RESIST group; Corripio I. Grasa E, et al. Among authors: alonso solis a. JMIR Form Res. 2023 Jun 30;7:e46179. doi: 10.2196/46179. JMIR Form Res. 2023. PMID: 37389933 Free PMC article.
Target selection for deep brain stimulation in treatment resistant schizophrenia.
Corripio I, Roldán A, McKenna P, Sarró S, Alonso-Solís A, Salgado L, Álvarez E, Molet J, Pomarol-Clotet E, Portella M. Corripio I, et al. Among authors: alonso solis a. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jan 10;112:110436. doi: 10.1016/j.pnpbp.2021.110436. Epub 2021 Sep 10. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34517055
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.
Alonso-Solís A, Ochoa S, Grasa E, Rubinstein K, Caspi A, Farkas K, Unoka Z, Usall J, Huerta-Ramos E, Isohanni M, Seppälä J, Reixach E, Berdún J, Corripio I, Group MR. Alonso-Solís A, et al. Int J Environ Res Public Health. 2020 Oct 16;17(20):7527. doi: 10.3390/ijerph17207527. Int J Environ Res Public Health. 2020. PMID: 33081208 Free PMC article.
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis.
González-Ortega I, González-Pinto A, Alberich S, Echeburúa E, Bernardo M, Cabrera B, Amoretti S, Lobo A, Arango C, Corripio I, Vieta E, de la Serna E, Rodriguez-Jimenez R, Segarra R, López-Ilundain JM, Sánchez-Torres AM, Cuesta MJ; PEPs Group:; Zorrilla I, López P, Bioque M, Mezquida G, Barcones F, De-la-Cámara C, Parellada M, Espliego A, Alonso-Solís A, Grasa EM, Varo C, Montejo L, Castro-Fornieles J, Baeza I, Dompablo M, Torio I, Zabala A, Eguiluz JI, Moreno-Izco L, Sanjuan J, Guirado R, Cáceres I, Garnier P, Contreras F, Bobes J, Al-Halabí S, Usall J, Butjosa A, Sarró S, Landin-Romero R, Ibáñez A, Selva G. González-Ortega I, et al. Among authors: alonso solis a. Psychol Med. 2020 Dec;50(16):2702-2710. doi: 10.1017/S0033291719002794. Epub 2019 Oct 22. Psychol Med. 2020. PMID: 31637990
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos E, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J; m-Resist group; Grasa EM. Alonso-Solís A, et al. BMJ Open. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346. BMJ Open. 2018. PMID: 30012788 Free PMC article.
17 results